Nicotine Transdermal System Patch, Extended Release
Product Images NDC 70000-0761

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nicotine Transdermal System (NDC 70000-0761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 110, Llc. Dba Leader, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Cardinal Nicotine Transdermal System Patch 14 mg Step 2)

FDA Label Image

Carton (Cardinal Nicotine Transdermal System Patch 21 mg Step 1)

FDA Label Image

Carton (Cardinal Nicotine Transdermal System Patch 7 mg Step 3)

Carton (Cardinal Nicotine Transdermal System Patch 7 mg Step 3)
This text appears to be information about nicotine transdermal system patches to aid in quitting smoking. The text includes suggestions to increase the success in quitting smoking, dosage instructions, and details about the product. The product seems to be at Step 3 of a smoking cessation program. It also mentions a behavior support program and a self-help guide. The text further includes information about the manufacturer and includes a registered trademark. Additional details such as directions, lot number, and expiration date are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.